Astellas Pharma (OTC: ALPMF)
$9.84
(3.6%)
$0.34
Price as of April 25, 2024, 2:14 p.m. ET
Astellas Pharma Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Astellas Pharma Company Info
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.